Update Course Rewind: Congenital Lung Lesions 2022

Why This Subspecialty Exists

Pediatric surgeons manage congenital lung lesions because prenatal ultrasound now detects structural anomalies that previous generations never saw until they caused symptoms. The incidence appears to be rising, but what has actually changed is detection — more screening means more findings 0:15. These lesions occupy an uncomfortable middle ground: most will never cause problems, some will trigger recurrent pneumonias, and a small fraction harbor malignancy. The challenge is distinguishing which lesion belongs in which category, ideally before the child spends years on antibiotics or develops bronchiectasis.

The Core Clinical Problem

Congenital lung lesions encompass a spectrum from incidental cysts to multilobar masses requiring pneumonectomy 3:35. The term CPAM (congenital pulmonary airway malformation) has become a catch-all in fetal imaging, often applied when the actual pathology remains unclear 2:52. Two risks drive surgical decision-making: malignancy and recurrent infection 0:23. Until recently, the relative weight of these risks was poorly quantified. The 2021 Midwest Pediatric Surgery Consortium series of 521 primary lung lesions from 11 children's hospitals provided the first large-scale risk stratification 1:07.

The data split cleanly on timing of diagnosis. No prenatally diagnosed lesions proved malignant 1:20. Roughly 10% of postnatally diagnosed lesions were malignant 1:24, with about half of those associated with DICER1 mutation 1:24. Bilateral disease and CT findings suspicious for malignancy predicted malignancy 1:40, but CT overall had poor sensitivity and specificity 1:36. Systemic feeding vessels, often cited as a concerning feature, were not associated with malignancy in this series 1:32. A separate review of approximately 400 cystic lesions found not a single case of pleuropulmonary blastoma (PPB) among antenatally diagnosed patients 1:48.

This creates a clinical fork. For prenatally diagnosed lesions, malignancy risk approaches — but does not reach — zero 1:59 2:21. For postnatally diagnosed lesions, the 10% malignancy rate demands resection. The debate centers on the asymptomatic prenatal finding: does near-zero risk justify observation, or does the non-zero tail risk mandate resection?

How the Approach Works

Many prenatally suspected lesions resolve or prove absent after birth — mucus plugs, transient findings, or imaging artifacts 2:37. Postnatal imaging with CT confirms or refutes the prenatal diagnosis, though the specificity remains imperfect. For confirmed lesions, the primary indication for resection has shifted from malignancy prevention to infection prevention 3:28. Children aged 4 to 9 years who present with recurrent pneumonias from unresected congenital lung lesions face technically difficult surgery with lower success rates for thoracoscopic resection compared to resection in the perinatal period or first year of life 3:13. Bronchiectasis from repeated infections becomes the long-term morbidity 3:28.

The discussants frame the decision as risk tolerance rather than protocol. One states plainly, "I take them all out" [q2], acknowledging that asymptomatic prenatally diagnosed lesions carry minimal but non-zero malignancy risk [q3]. Another emphasizes infection risk in counseling: "When I counsel parents, I say it's not the cancer. I worry about these recurrent pneumonias and real problems with bronchiectasis" [q4]. The spectrum of pathology — from trivial cysts to lesions requiring pneumonectomy — means management must be individualized [q5].

Where Practice Remains Contested

The asymptomatic prenatally diagnosed lesion generates the most debate. The Consortium data and the 400-lesion cystic series both show zero malignancies in this group, but zero in a finite series is not the same as impossible. Some surgeons argue that near-zero risk does not justify surgery in an asymptomatic child. Others argue that leaving a lesion in place indefinitely means eventually encountering the undiagnosed malignancy. The discussion does not resolve this tension — it acknowledges that practice is evolving as data accumulate 2:56.

Timing of resection also lacks consensus. Early resection (perinatal or first year) offers technical advantages and prevents the infectious complications that make later surgery harder 3:13. But early resection also operates on lesions that might never cause symptoms. The discussants agree that management should be tailored to the actual pathology 3:50, but prenatal and early postnatal imaging cannot always predict which lesions will declare themselves clinically.

When to Involve This Team

Refer any child with a prenatally diagnosed lung lesion for postnatal evaluation, even if asymptomatic. Refer any child with a postnatally diagnosed lung lesion — the 10% malignancy rate in this group makes observation untenable 1:24. Refer before recurrent pneumonias begin, not after. A child with two or three pneumonias in the same lobe and a known congenital lesion has already crossed the threshold where surgery becomes more difficult and outcomes worse 3:13. The discussion does not specify exact referral criteria for asymptomatic prenatal findings, reflecting the lack of consensus in the field, but the weight of opinion favors resection over observation for confirmed lesions.